跳至主要内容
临床试验/NCT03775655
NCT03775655已完成2 期

Low Dose Hyperbaric Bupivacaine and Dexmedetomidine as an Adjuvant, Caesarean Section: Randomized Controlled Trial

Menoufia University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2018年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
40
试验地点
1
主要终点
Haemodynamic stability and total doses of IV fluids and vasopressors

研究概览

简要总结

The aim of this study is to evaluate the effectiveness of low dose scheme with dexmedetomidine as an adjuvant. Taking in consideration optimum intraoperative surgical conditions, best post-operative pain free experience, and more stable hemodynamic.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Full-term pregnant women
  • Singleton gestation
  • American Society of Anaesthesiologists (ASA) physical status classes II and I

排除标准

  • Preterm pregnancy (<37 wks. gestation)
  • Multiple gestation
  • Cardiovascular disease (e.g., preeclampsia, hypertension) and the use of antihypertensive medications
  • Asthma and allergy to non-steroidal anti-inflammatory drugs
  • Conditions that prevent spinal anaesthesia
  • Failed spinal block and conversion to general anaesthesia
  • A history of established chronic pain
  • Drug addiction
  • A psychiatric disorder
  • Inability to communicate effectively

研究组 & 干预措施

LD-DEX

Active Comparator

This group will receive 7mg hyperbaric bupivacaine (about 1.4 ml of hyperbaric bupivacaine 0.5%) and 10μg dexmedetomidine (10 unit by U-100 insulin syringe using a preservative free dexmedetomidine 100μg/ml).

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Haemodynamic stability and total doses of IV fluids and vasopressors

时间窗: Intraoperative

Density of motor and sensory blockade

时间窗: Intraoperative

Time to first postoperative rescue analgesic request

时间窗: 24 hour

次要结局

  • Hospital in stay(24 hour)
  • The peak sensory level of block(Intraoperative)
  • Time from intrathecal injection to peak sensory block level(Intraoperative)
  • The intraoperative patient and surgeon satisfaction (successful delivery)(Intraoperative)
  • The time to two sensory block segment regression(Intraoperative and 24 hour)
  • Degree and duration of motor block(Intraoperative and 24 hour)
  • Postoperative pain scores for 24 hours(24 hour)
  • Intraoperative and postoperative sedation scores(Intraoperative and 24 hour)
  • Intraoperative analgesic supplementation during operation(Intraoperative)
  • Incidence of side effects: nausea, vomiting, shivering, pruritus, respiratory depression, and desaturation.(Intraoperative and 24 hour)
  • Frequency and total dose of postoperative analgesics(24 hour)
  • Time to S1 level sensory regression(Intraoperative and 24 hour)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Ashraf Nasr

Assisstant Lecturer Anesthesia, Intensive care and Pain management - Faculty of Medicie - Menoufia University

Menoufia University

研究点 (1)

Loading locations...

相似试验